Coya Therapeutics Inc
XNAS:COYA   4:00:00 PM EDT
							| Market Cap (Intraday) | 100.46M | 
| Current PE | N/A | 
| Forward PE | N/A | 
| 2yr Forward PE | N/A | 
| 10-Day MA | $6.35 | 
| 50-Day MA | $6.20 | 
| 200-Day MA | $6.11 | 
Coya Therapeutics Inc Stock, XNAS:COYA
5850 San Felipe Street, Suite 500, Houston, Texas 77057
					United States of America
				Phone: +1.800.587.8170
				Number of Employees: 8
								
				
			Description
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.


